The global asthma therapeutics market benefits from demand for combination inhalers containing inhaled corticosteroids and long-acting beta₂-agonists. These formulations can improve symptom control and simplify treatment regimens for patients who need more than an inhaled corticosteroid alone.
The asthma therapeutics market is projected to reach US$ 37.86 billion by 2031, registering a CAGR of...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek